Clinical Trials Directory

Trials / Completed

CompletedNCT05648318

Comparison of Oral Lactulose Versus Polyethylene Glycol for Bowel Preparation in Low-risk Patients

1L Oral Lactulose is an Effective Regimen for Bowel Preparation in Low-risk Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
255 (actual)
Sponsor
Zhang Xiaofeng,MD · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

Adequate quality of bowel preparation(BP) is essential for colonoscopy. In recently, Kang suggested that for low-risk patients, single dose of 2L PEG is an effective regimen for bowel preparation.However, due to the poor palatability, there still more than 30% patients with 2L regimen experienced nausea or vomiting in our center. Oral lactulose is a treatment for constipation. Several studies have compared the effectiveness between use PEG and lactulose for colonoscopy preparation in average-risk patients. However, the data in low-risk patients is vacant. The objective of current study was to compared the effectiveness of bowel preparation and patient tolerance using lactulose and 2L PEG regimen in low-risk patients.

Conditions

Interventions

TypeNameDescription
DRUGLactulose oral solutionIn the LOS group, patients were instructed to drink 200ml lactulose (Duphalac, Olst, the Netherlands; 200ml/bottle) diluted with clear water into 1L 4-6h before colonoscopy at a rate of 250ml every 30min.
DRUGPEGpatient in the PEG group were instructed to drink 2L of PEG (each liter containing 59g PEG 4000, 1.46g sodium chloride, 5.68g sodium sulfate, 0.74g potassium chloride, 1.68g sodium bicarbonate; WanHe Pharmaceutical Co, Ltd., China) 4-6h before colonoscopy at a rate of 250ml every 15min

Timeline

Start date
2022-01-08
Primary completion
2022-09-12
Completion
2022-09-12
First posted
2022-12-13
Last updated
2022-12-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05648318. Inclusion in this directory is not an endorsement.